Bayer AG

Equities

BAYN

DE000BAY0017

Market Closed - Xetra Other stock markets 11:35:12 2026-06-05 am EDT			5-day change	1st Jan Change
36.16 ^EUR	+1.69%		-1.01%	-2.30%

Jun. 05	Study: Bayer's Finerenone slows progression of chronic kidney disease	RE
Jun. 05	Bayer Announces Phase III FIND-CKD Results For KERENDIA In Non-Diabetic Chronic Kidney Disease	CI

Transcript : Bayer Aktiengesellschaft, Q1 2026 Earnings Call, May 12, 2026

Published on 05/12/2026 at 09:35 am EDT - Modified on 05/12/2026 at 04:51 pm EDT

S&P Capital IQ

Presenter Speech
Jost Reinhard (Executives)

Good afternoon and good morning, everybody, and welcome to our conference call to present the first quarter results for 2026. We'll keep today's remarks

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Bayer AG

Jun. 05	Study: Bayer's Finerenone slows progression of chronic kidney disease	RE
Jun. 05	Bayer Announces Phase III FIND-CKD Results For KERENDIA In Non-Diabetic Chronic Kidney Disease	CI
Jun. 05	BAYER AG : UBS maintains a Buy rating	ZD
Jun. 05	UBS maintains 'Buy' rating on Bayer - Target 52 euros	DP
Jun. 05	Bayer CEO: Hormuz Blockade Threatens Harvests - Criticism of Germany as a Business Hub	RE
Jun. 04	Top cases on the US Supreme Court's docket	RE
Jun. 03	Wall Street's Record Highs Are Starting to Look a Little Narrow
Jun. 03	AlphaValue/Baader Europe Upgrades Bayer to Buy, Trims PT	MT
Jun. 03	Mwb Says Bayer Valuation Discounts US Legal Overhang; Buy Rating Kept	MT
Jun. 03	Bayer Rating Maintained at Buy as BofA Notes Transfer of Roundup Class Action Lawsuit	MT
Jun. 03	Europe wants to get back into the technology race
Jun. 02	Bayer Denies Restructuring Plans Despite Monsanto Lawsuits	MT
Jun. 02	Bayer says no plans to restructure despite litigation threat	RE
Jun. 02	Health Care Down as Traders Rotate to Other Defensive Sectors -- Health Care Roundup	DJ
Jun. 02	Germany's Blue-chip DAX Index Gains; Eurozone Inflation Accelerates	MT